(IN BRIEF) The global health NGO Deutsche Stiftung Weltbevölkerung (DSW) is calling on the European Union (EU) to establish a priority review program aimed at encouraging investment in research and innovation (R&I) to combat poverty-related and neglected infectious diseases. Over … Read the full press release
Posted in Belgium, European Union, Healthcare, Non Profit, Pharma & Biotech, Society
Tagged antibodies for HIV, David Reddy, Deutsche Stiftung Weltbevölkerung, DSW, EDCTP, EU priority review programme, European Union, global health, health NGO, Hester Kuipers, IAVI, infectious diseases, Lisa Goerlitz, Malaria Venture, medical need, MMV, neglected infectious diseases, Professor John Reeder, TB, TDR, vaccines, World Health Organization
(IN BRIEF) Kuehne+Nagel’s North American Road Logistics team received an urgent request from a pharmaceutical customer to deliver 150 pallets of flu vaccines to over 40 Veterans Affairs (VA) hospitals across the U.S. within ten days. The team quickly organized … Read the full press release
(IN BRIEF) AstraZeneca is set to present new data at the 12th annual IDWeek conference, emphasizing the role of long-acting antibodies and vaccines in safeguarding at-risk individuals from common infectious respiratory diseases. The company will share 15 abstracts, including oral … Read the full press release
(IN BRIEF) AstraZeneca is set to present data on its Vaccines and Immune Therapies portfolio at the European Congress of Clinical Microbiology & Infectious Diseases. Among the data to be presented will be details on the progress of AstraZeneca’s Vaccines … Read the full press release
Posted in Business, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, AZD3152, Beyfortus, ECCMID 2023, Evusheld, Immune Therapies, Iskra Reic, vaccines, Vaxzevria
(PRESS RELEASE) MELBOURNE, Australia, 3-Feb-2022 — /EuropaWire/ — Australian technologist Dr Ian Dixon founded Exopharm in 2013 with the vision to harness the unique properties of exosomes as a new class of medicine. Dixon’s decisive early entry into exosome therapeutics … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Technology
Tagged AAVs, adeno-associated viral vectors, Arch Ventures, Australian technologist, Biotech, Codiak Biociences, Daisy Scarborough, DNA/RNA, Dr Ian Dixon, Evox Therapeutics, EVPS, Exopharm, Exoria, exosome therapeutics, exosomes, gene therapies, genetic disorders, LEAP™, lipid nanoparticles, LNPs, LOAD, Lonza, medicine, Pharmaceutical, vaccines
(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion of its Glasgow biosafety testing facility thus helping to accelerate quality testing and reduce turnaround time for its clients. The … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Archie Lovatt, biological medicines, biologics, biologics manufacturers, biopharmaceutical, Biosafety Center of Excellence, BSL-2 cabinets, cell culture, cell therapies, COVID-19 vaccine, drug development, ELISA, gene therapies, Glasgow, Good Laboratory Practices, Good Manufacturing Practices, laboratories, monoclonal antibodies, polymerase chain reaction, real-time PCR testing, SGS, vaccines, virus detection
(PRESS RELEASE) SINGAPORE, 22-Jul-2021 — /EuropaWire/ — Kuehne+Nagel, one of the world’s leading logistics companies, has announced that its subsidiary QuickSTAT has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT’s … Read the full press release
Posted in Business, Healthcare, Industrial, Infrastructure & Utilities, News, Pharma & Biotech, Switzerland, Transportation & Logistics
Tagged biologics, biomedical science hub, cell therapy, clinical research samples, clinical trial logistics, clinical trial supplies, conditioning facility, control tower, Cyril Leger, gene therapy, Healthcare, Healthcare Logistics, investigational drugs, investment, Jack Liu, Kuehne+Nagel, logistics, pharma, pharmaceutical product lifecycle, QuickSTAT, Singapore, time and temperature shipping, vaccines
Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global nonprofit unit to provide 40 of the world’s poorest countries access to 30 essential medicines (PRESS RELEASE) PARIS, 7-Apr-2021 — … Read the full press release
Posted in France, Healthcare, News, Non Profit, Pharma & Biotech, Society
Tagged access to medicines, Cancer, cardiovascular disease, chronic diseases, climate change, Corporate Social Responsibility, CSR strategy, Diabetes, diversity, environmental protection program, Fabry, Gaucher, healthcare professionals, Inclusion, malaria, nonprofit unit, open letter, Paul Hudson, Pharmaceutical, Planet Mobilization, polio, Pompe diseases, preservation of the environment, rare diseases, Sanofi, Sanofi Global Health, sleeping sickness, support for vulnerable communities, tuberculosis, vaccines, WHO, World Health Organization, Zero plastic packaging
New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 — /EuropaWire/ — Global transport and logistics company Kuehne+Nagel announces international supply chain arrangement with Moderna, Inc. (NASDAQ:MRNA), a biotechnology company … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Switzerland, Technology, Transportation & Logistics
Tagged biotechnology, Covid-19 Vaccine Moderna, Dan Staner, distribution, Dominique Nadelhofer, EMA, European Medicines Agency, Harriet Barham, Kuehne+Nagel, logistics, messenger RNA, Moderna, mRNA, pandemic, pharma hub, QuickSTAT, Robert Coyle, Storage, supply chain, therapeutics, vaccines, Warehousing
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. The test targets antibodies against the spike protein. This is the focus of vaccines in development … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Switzerland
Tagged Anti-SARS-CoV-2 S, antibodies, antibody test, COVID-19, Elecsys Anti-SARS-CoV-2 S test, Elecsys Anti-SARS-CoV-2 serology test, Elecsys®, Emergency Use Authorisation, EUA, FDA, Roche, SARS-CoV-2, SARS-CoV-2 vaccine, Thomas Schinecker, vaccines
(PRESS RELEASE) PARIS and LEXINGTON, MA, U.S.A, 27-Mar-2020 — /EuropaWire/ — Sanofi Pasteur collaborates with Translate Bio (NASDAQ: TBIO) to develop a novel mRNA vaccine for COVID-19. Both companies will jointly investigate multiple candidates with the goal of advancing an … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech, Science
Tagged BARDA, Biomedical Advanced Research and Development Authority, COVID-19, David Loew, infectious diseases, messenger RNA, mRNA, novel mRNA vaccine, pandemic response, Ronald Renaud, Sanofi, Sanofi Pasteur, SARS-CoV-2 vaccine candidates, therapeutics, Translate Bio, vaccines
WACKER TAKES OVER SYNCO BIO PARTNERS OF AMSTERDAM CAPACITY OF ACQUIRED FERMENTATION PLANT FOR PHARMACEUTICAL ACTIVES TOTALS SOME 2,000 LITERS – WACKER BIOTECH’S OVERALL CAPACITY DOUBLES AS A RESULT SYNCO’S EXPERTISE IN MANUFACTURING LIVE MICROBIAL PRODUCTS AND IN FILLING FINISHED … Read the full press release
New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint London and Philadelphia, 6-4-2015 — /EuropaWire/ — GSK announced today it is further strengthening and expanding its vaccines presence in the US by establishing a new global centre … Read the full press release
Posted in Healthcare, Management, Pharma & Biotech, Science, Technology, United Kingdom
Tagged global centre for vaccines R&D, GSK, Larry Hogan, Luc Debruyne, vaccines
14-6-2013 — /europawire.eu/ — Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria parasites growing inside red blood cells stick to the sides of … Read the full press release
Posted in Denmark, Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged Assistant Professor Louise Turner, Assistant Professor Thomas Lavstsen, blood vessels, combat malaria, DRUGS, endothelial, endothelial protein C, EPCR, malaria, Malaria parasites, malaria symptoms, NIMR Tanzania, parasite, parasite proteins, PfEMP1, regulating blood coagulation, Retrogenix LTD, Seattle Biomedical Research Institute, University of Copenhagen, University of Oxford, vaccines
Brussels, 29-4-2013 — /europawire.eu/ — An EU-funded research project aims to start testing a new diagnostic tool for malaria one year ahead of schedule. The pioneering smartphone-like device uses cutting-edge nanotechnology to detect not only the malaria infection but also any drug … Read the full press release
Posted in Belgium, Education, Electronics & Machinery, European Union, Financial, Government, Healthcare, Pharma & Biotech, Politics, Science, Society, Technology
Tagged anti-malarial drugs, diagnostic tool, diagnostic tool for malaria, disease, DNA sequencing, DRUGS, EU-funded, handheld diagnostics, Karolinska Institute, Máire GEOGHEGAN-QUINN, malaria, malaria infection, malaria research, Nanomal, nanotechnology, pinprick of blood, prototype device, QuantuMDx Group, St George’s, University of London, University of Tuebingen, vaccines
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
